Hepatic overexpression of miR-34a resulted in impaired insulin signaling and disrupted glucose metabolism in hepatocytes, further implicating miRNAs in the metabolic dysregulation associated with MASLD [61]. This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.